1. What Is the Focused Ultrasound Therapy Market?
The Focused Ultrasound Therapy Market comprises non-invasive therapeutic systems that concentrate ultrasound energy at a focal point within the body to ablate tissue or open biological barriers without incision. The market includes MRI-guided focused ultrasound ablation systems, HIFU therapeutic platforms, blood-brain barrier opening devices, and single-element and phased array ultrasound therapy transducers. These systems serve neurosurgeons, urologists, oncologists, and neuroscientists treating essential tremor, uterine fibroids, prostate disease, and central nervous system drug delivery applications. The scope excludes diagnostic ultrasound imaging systems, intravascular and endoscopic ultrasound, and therapeutic ultrasound physiotherapy devices for musculoskeletal pain management.
2. Focused Ultrasound Therapy Market Size & Forecast
3. Emerging Technologies
- Adaptive focused ultrasound systems using real-time acoustic feedback are advancing to maintain focal spot accuracy during thermal ablation despite tissue movement and temperature-related speed changes. Growing deployment of adaptive feedback control is improving thermal dose accuracy and reducing off-target heating during focused ultrasound CNS treatment.
- Low-intensity pulsed ultrasound neuromodulation systems are advancing for non-destructive modulation of deep brain circuits as an alternative to transcranial magnetic stimulation. Increasing development of transcranial ultrasound neuromodulation is enabling deep target stimulation with better spatial resolution than surface electrical or magnetic approaches.
- Wearable focused ultrasound delivery systems are advancing for repeated blood-brain barrier opening sessions without each requiring full MRI guidance in a radiology suite. Continued miniaturization of ultrasound transducer arrays is improving chronic repeated delivery protocols for central nervous system drug delivery and neuromodulation.
- AI treatment planning systems for focused ultrasound are advancing to compute personalized focal spot parameters from patient skull geometry and tissue composition data. Expanding AI skull modeling is improving CNS treatment accuracy for patients with variable skull density ratios that affect acoustic wave propagation.
Comparable technologies are influencing adjacent market segments in similar ways. Read more in our Magnetic Resonance Imaging Mri Contrast Agent Market.
4. Key Market Opportunity
One of the key opportunities in the Focused Ultrasound Therapy Market is the clinical validation and regulatory expansion of focused ultrasound blood-brain barrier opening for chemotherapy delivery in glioblastoma patients with limited current systemic drug penetration to brain tumors. Most chemotherapy drugs are excluded from brain tumor tissue by the blood-brain barrier, limiting effective drug concentrations despite systemic administration at full therapeutic doses. Advances in pulsed microbubble focusing, transducer targeting accuracy, and MRI monitoring of opening localization are enabling controlled and repeatable BBB opening at tumor sites. Focused ultrasound developers achieving glioblastoma drug delivery enhancement outcomes data stand to define a new treatment enhancement standard for neuro-oncology therapy.
5. Top Companies in the Focused Ultrasound Therapy Market
The following organisations hold leading positions in the Focused Ultrasound Therapy Market. The full report provides revenue share, SWOT analysis, and competitive benchmarking for each player.
- Insightec (Exablate)
- Profound Medical
- EDAP TMS (Focal One)
- Theraclion
- Sonablate (SonaCare)
- HistoSonics
- FUS Instruments
- Carthera
- SciSparc
- Alpinion Medical Systems
- EkoSonic (Boston Scientific)
- Sonic Incytes
6. Market Segmentation
The Focused Ultrasound Therapy Market is analysed across 6 segmentation dimensions. Revenue data, growth rates, and competitive intensity by sub-segment are available in the full report.
| Segmentation | Sub-Segments |
|---|---|
| By Technology | MRI-Guided Focused Ultrasound Exablate Platform High-Intensity Focused Ultrasound HIFU Focused Ultrasound BBB Opening Low-Intensity Transcranial Ultrasound |
| By Application | Essential Tremor Treatment Parkinson's Disease Tremor Uterine Fibroid Ablation Prostate Disease Treatment Blood-Brain Barrier Opening Drug Delivery to CNS Oncological Tumor Ablation |
| By Guidance Imaging | MRI-Guided Treatment Ultrasound-Guided HIFU CT-Guided Focused Ultrasound |
| By Setting | Neurosurgery Suite with MRI Radiology Interventional Suite Urology Ambulatory Center Oncology Treatment Center |
| By End User | Neurosurgeons and Neurologists Urologists Interventional Radiologists Neuroscience Research Programs Oncologists |
| By Geography | North America The U.S. Canada Europe The UK Germany France Italy Spain Denmark Netherlands Finland Sweden Norway Russia Austria Poland Rest of Europe Asia Pacific China Japan India South Korea Australia Indonesia Vietnam Philippines Singapore Taiwan Thailand Rest of Asia Pacific Latin America Brazil Mexico Argentina Rest of South America Middle East and Africa GCC Countries Israel South Africa Rest of Middle East and Africa |
7. Key Market Trends (2026–2034)
Three major forces are shaping the Focused Ultrasound Therapy Market trajectory over the forecast period:
MRI-Guided Focused Ultrasound Is Expanding CNS Indications Beyond Essential Tremor.Neurosurgeons and neurologists are advancing focused ultrasound for Parkinson's disease tremor, OCD, and other movement disorders following the established outcomes of essential tremor treatment. Insightec advanced the Exablate Neuro MRI-guided focused ultrasound system in 2024, obtaining expanded FDA clearance for Parkinson's disease tremor treatment alongside existing essential tremor indication.
Blood-Brain Barrier Opening With Focused Ultrasound Is Advancing Drug Delivery to the CNS.Neuroscientists and oncologists are using low-intensity focused ultrasound with microbubbles to transiently open the blood-brain barrier, enabling therapeutic drug delivery to brain tumors and neurological disease. InSightec and Carthera progressed clinical programs for focused ultrasound blood-brain barrier opening in 2024, evaluating therapeutic delivery enhancement in glioblastoma and Alzheimer's disease.
HIFU Is Being Adopted for Whole-Gland Prostate Ablation as Minimally Invasive Therapy.Urologists are using high-intensity focused ultrasound for transrectal prostate ablation in localized prostate cancer, offering a minimally invasive alternative to radiation or surgery with favorable side effects. EDAP TMS advanced its Focal One robotic HIFU prostate ablation system clinical evidence in 2024, reporting outcomes data for focal and whole-gland prostate cancer treatment programs.
For related market intelligence, see the Magnetic Resonance Imaging Mri Scanner Market.
8. Segmental Analysis
By Application, essential tremor treatment dominated the Focused Ultrasound Therapy Market in 2025, driven by FDA clearance and established reimbursement for MRI-guided thalamotomy. Neurologists and neurosurgeons continue directing focused ultrasound investment toward essential tremor owing to established regulatory clearance and payer coverage frameworks. Blood-brain barrier opening is the fastest-growing Application category, driven by oncology and neurology programs exploring focused ultrasound for CNS drug delivery enhancement. Neuroscientists and oncologists are advancing BBB opening programs as glioblastoma and Alzheimer's disease drug delivery clinical evidence accumulates from early-phase trials.
By Technology, MRI-guided focused ultrasound dominated the Focused Ultrasound Therapy Market in 2025, reflecting its established clinical approval and image-guided precision for CNS applications. Neurosurgeons and neurologists continue specifying MRI guidance owing to real-time temperature mapping capability and regulatory approval for closed-loop thermal dose control. Focused ultrasound BBB opening is the fastest-growing Technology category, driven by pulsed microbubble applications that use lower intensity than thermal ablation and require different equipment. Developers are advancing BBB opening platforms as the application requires separate optimization from thermal ablation and may utilize wearable or outpatient delivery formats.
9. Regional Analysis
Regional demand patterns across the Focused Ultrasound Therapy Market reflect differences in regulation, technological maturity, and capital investment.
Largest Market Share
North America dominated the Focused Ultrasound Therapy Market in 2025, with a market share of 48.4%. FDA clearances for Exablate essential tremor and Parkinson's treatment, concentrated neurosurgery MRI-guided therapy programs, and the Focused Ultrasound Foundation located in the US anchor revenue. US neurology centers and academic medical programs adopting MRI-guided focused ultrasound generate the primary commercial focused ultrasound ablation procedure volumes globally. Strong NIH and Department of Defense funding for focused ultrasound research programs is sustaining preclinical and early clinical BBB opening and neuromodulation development.
Highest CAGR Region
Europe is expected to register the highest CAGR of 24.80% during the forecast period. EU-approved HIFU and focused ultrasound systems, academic clinical trial programs in the UK, Germany, and France, and European BBB opening clinical programs are driving adoption. CE-marked Exablate, Focal One, and Theraclion HIFU systems are operating across European academic medical centers for neurology, urology, and thyroid treatment indications. European neuroscience programs and ERC-funded CNS drug delivery research are advancing focused ultrasound applications for neurological disease beyond tremor treatment.
10. Full Report with Exclusive Insights
The complete published market report includes an in-depth analysis of market dynamics, industry trends, competitive landscape, regional outlook, and future growth opportunities. The study provides detailed market sizing and forecasts across key segments and geographies, along with comprehensive insights into drivers, restraints, opportunities, challenges, technological advancements, regulatory landscape, and evolving consumer and industry trends. The report also features company profiles, strategic developments, market share analysis, and actionable recommendations to support informed business decision-making. Additionally, the syndicated report package typically includes forecast datasets, charts and figures, research methodology, and analyst support for strategic interpretation and planning.
Advanced Strategic & Custom Intelligence
In addition to the standard syndicated report package, TrendX Insights can provide the following advanced strategic analyses and customized intelligence solutions for any market:
Standard Report Coverage
- • Competitor Analysis
- • Country Trade Analysis
- • Import & Export Analysis
- • Porter’s Five Forces Analysis
- • SWOT Analysis by Companies
- • TrendX Insights Quadrant Positioning
- • Pricing Analysis
- • Detailed Macro-Economic Indicators Assessment
- • List of Raw Material Suppliers
- • Regulatory Framework Assessment
- • Supply Chain Resilience Mapping
- • Value Chain Analysis
- • Technology Adoption Trends and Innovation Tracking
- • Custom Company Profiling and Benchmarking
Exclusive Sections With Additional Cost
- • Agentic AI Readiness Score
- • TAM, SAM, and SOM Analysis
- • AI Act & Privacy Compliance Audit
- • Channel Partner Ecosystem Mapping
- • China + 1 Strategy Analysis
- • Circular Economy Opportunities Assessment
- • Competitor Benchmarking KPI Analysis
- • Country-Level Opportunity Mapping
- • Digital Maturity Matrix
- • Ecosystem Interdependency Mapping
- • ESG & Decarbonization Roadmap
- • Geopolitical Friction Scorecard
- • Geopolitical Risk Assessment
- • Humanoid Workforce Impact Analysis
- • Investment Heatmap
- • List of Distributors and Channel Partners
- • Market Entry Strategy Assessment
- • Mergers & Acquisitions (M&A) Analysis
- • Patent & Intellectual Property (IP) Analysis
- • Pilot Project Analysis
- • Potential High-Growth Region/Country Investment Assessment
- • Product Comparison Analysis
- • Product Revenue Analysis
- • R&D Investment Analysis in Emerging Technologies
- • Raw Material Scarcity Forecast
Note: For highly customized requirements, deeper strategic assessments, company-specific intelligence, or tailored consulting support, please contact TrendX Insights.
Full Report with Exclusive Insights
Available to clients on request
Explore Our Published Reports Library
This page covers market-level data estimates. For comprehensive published research reports including full methodology, primary data, and detailed company profiles, browse the TrendX Insights Published Reports Library.
Visit Published Reports Library ›11. Related Market Reports
Frequently Asked Questions
The Focused Ultrasound Therapy Market was valued at USD 841.84 Mn in 2025 and is projected to reach USD 4,279.00 Mn by 2034, growing at a CAGR of 19.80% over the 2026–2034 forecast period.
The Focused Ultrasound Therapy Market is projected to grow at a CAGR of 19.80% from 2026 to 2034.
North America dominated the Focused Ultrasound Therapy Market in 2025, with a market share of 48.4%.
The leading companies in the Focused Ultrasound Therapy Market include Insightec (Exablate), Profound Medical, EDAP TMS (Focal One), Theraclion, Sonablate (SonaCare), HistoSonics, FUS Instruments, Carthera, SciSparc, Alpinion Medical Systems, EkoSonic (Boston Scientific), Sonic Incytes.
Mri-guided focused ultrasound is expanding cns indications beyond essential tremor.
By Application, essential tremor treatment dominated the Focused Ultrasound Therapy Market in 2025, driven by FDA clearance and established reimbursement for MRI-guided thalamotomy.
How to Order
Purchasing a TrendX Insights report is straightforward. Our process is designed to be transparent and risk-free for buyers, with a 20% upfront model and full delivery before the balance payment.
This is the price of the syndicated report. Any custom inclusions beyond the Table of Contents will be scoped and priced separately. For the full list of what is covered in the syndicated report, refer to the Table of Contents tab.
A curated, condensed version of this report for students, researchers, and academic institutions. Ideal for thesis work, dissertations, and academic projects. Delivered as PDF to your institutional email.
Valid student ID or institutional email required. For educational and non-commercial use only.